Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer. [electronic resource]
Producer: 20010809Description: 482-7 p. digitalISSN:- 0022-5347
- Antimetabolites, Antineoplastic -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Blotting, Western
- Cell Death
- Cell Line
- Deoxycytidine -- analogs & derivatives
- Drug Screening Assays, Antitumor
- Humans
- Immunohistochemistry
- Mutation
- Paclitaxel -- pharmacology
- Transfection
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53 -- genetics
- Urinary Bladder Neoplasms -- drug therapy
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.